JP2023510158A5 - - Google Patents

Info

Publication number
JP2023510158A5
JP2023510158A5 JP2022539136A JP2022539136A JP2023510158A5 JP 2023510158 A5 JP2023510158 A5 JP 2023510158A5 JP 2022539136 A JP2022539136 A JP 2022539136A JP 2022539136 A JP2022539136 A JP 2022539136A JP 2023510158 A5 JP2023510158 A5 JP 2023510158A5
Authority
JP
Japan
Application number
JP2022539136A
Other languages
Japanese (ja)
Other versions
JP2023510158A (ja
JPWO2021133904A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/066828 external-priority patent/WO2021133904A1/en
Publication of JP2023510158A publication Critical patent/JP2023510158A/ja
Publication of JP2023510158A5 publication Critical patent/JP2023510158A5/ja
Publication of JPWO2021133904A5 publication Critical patent/JPWO2021133904A5/ja
Pending legal-status Critical Current

Links

JP2022539136A 2019-12-27 2020-12-23 細菌及び微生物細胞外小胞を含有する固形剤形 Pending JP2023510158A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962954153P 2019-12-27 2019-12-27
US62/954,153 2019-12-27
PCT/US2020/066828 WO2021133904A1 (en) 2019-12-27 2020-12-23 Solid dosage forms containing bacteria and microbial extracellular vesicles

Publications (3)

Publication Number Publication Date
JP2023510158A JP2023510158A (ja) 2023-03-13
JP2023510158A5 true JP2023510158A5 (https=) 2024-01-05
JPWO2021133904A5 JPWO2021133904A5 (https=) 2024-01-05

Family

ID=74626080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022539136A Pending JP2023510158A (ja) 2019-12-27 2020-12-23 細菌及び微生物細胞外小胞を含有する固形剤形

Country Status (13)

Country Link
US (1) US20230355689A1 (https=)
EP (1) EP4081195A1 (https=)
JP (1) JP2023510158A (https=)
KR (1) KR20220128362A (https=)
CN (1) CN114945357A (https=)
AR (1) AR122353A1 (https=)
AU (1) AU2020413225A1 (https=)
BR (1) BR112022012514A2 (https=)
CA (1) CA3165418A1 (https=)
CO (1) CO2022010242A2 (https=)
MX (1) MX2022007943A (https=)
TW (1) TW202135783A (https=)
WO (1) WO2021133904A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021252861A1 (en) * 2020-06-11 2021-12-16 Evelo Biosciences, Inc. Compositions and methods for treating diseases and disorders using megasphaera sp
KR20230053609A (ko) * 2020-07-21 2023-04-21 에벨로 바이오사이언시즈, 인크. 신경염증성 질환에 대한 경구 요법으로서의 베일로넬라 파르불라 균주
US20250114411A1 (en) * 2021-09-24 2025-04-10 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
JP2024542749A (ja) * 2021-12-16 2024-11-15 エンテロバイオーム インコーポレイテッド がん又は炎症性疾患予防又は治療用薬学的組成物
CN115252651B (zh) * 2022-06-08 2024-06-07 广州知易生物科技有限公司 嗜粘蛋白阿克曼菌在制备防治高血压的组合物中的应用和含有其的组合物
CA3266547A1 (en) * 2022-08-29 2024-03-07 Eli Lilly And Company COMPOSITIONS FOR ORAL ADMINISTRATION
CN116509900B (zh) * 2022-12-01 2023-11-10 佛山科学技术学院 益生菌或其细胞外囊泡在制备防治胃溃疡产品中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775536A (en) 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US5292522A (en) 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
US5047258A (en) 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
DE19631084A1 (de) 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6312728B1 (en) 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
DE69924735T2 (de) 1998-07-28 2006-01-19 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
US20040028737A1 (en) 2002-08-12 2004-02-12 Kopran Research Laboratories Limited Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
DE10260919A1 (de) 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
US20070065513A1 (en) 2003-10-31 2007-03-22 Avi Avramoff Stable lansoprazole formulation
US9149439B2 (en) 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
DE102005032806A1 (de) 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
CN101209247B (zh) * 2006-12-27 2011-12-14 天津中新药业集团股份有限公司 一种结肠靶向制剂的制备方法
CN101757042A (zh) * 2009-05-25 2010-06-30 北京诚创康韵医药科技有限公司 一种益生菌微丸制剂及其制备
CA3212215A1 (en) * 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA2903375C (en) 2013-03-01 2020-11-24 Bpsi Holdings, Llc. Delayed release film coatings containing calcium silicate and substrates coated therewith
AU2014239883B2 (en) * 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
CN111712260A (zh) * 2018-01-31 2020-09-25 伊夫罗生物科学公司 使用毛螺菌科细菌治疗免疫病症的组合物和方法

Similar Documents

Publication Publication Date Title
BR112021014123A2 (https=)
JP2023510158A5 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023011539A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016200A2 (https=)
BR102021016176A2 (https=)
BR102021015566A2 (https=)
BR102021015450A8 (https=)
BR102021015247A2 (https=)
BR102021015220A2 (https=)
BR102021014044A2 (https=)
BR102021014056A2 (https=)